Skip to main content
. 2017 Dec 9;6(12):e006910. doi: 10.1161/JAHA.117.006910

Figure 4.

Figure 4

Cardiovascular mortality. Forrest plot showing the odds ratio for cardiovascular mortality with PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors (PCSK9i) compared with no PCSK9i. The pooled odds ratio was calculated with random effects according to the Mantel‐Haenszel (M‐H) method. Marker size is proportional to the study weight. CI indicates confidence interval.